CoChat

Gadolinium Oxide Nanoparticles Reinforce the Fractionated Radiotherapy-Induced Immune Response in Tri-Negative Breast Cancer via cGAS-STING Pathway

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

Introduction: Radiotherapy is a widely recognized first-line clinical treatment for cancer, but its efficacy may be impeded by the radioresistance of advanced tumors. It is urgent to improve the sensitivity of radioresistant tumors to radiotherapy. In this work, gadolinium oxide nanocrystals (GONs) were utilized as radiosensitizers to enhance the killing effect and reinforce the immune activation of X-ray irradiation on 4T1 breast cancer cells in vitro and in vivo. Methods: 1.0 T small animal MR imaging (MRI) system was employed to trace GONs in vivo, while 225 kVp X-ray irradiation equipment was utilized for investigating the radiosensitization of GONs in 4T1 breast cancer cells in vitro and in vivo. Western blot, quantitative real-time PCR (RT-qPCR), immunohistochemistry, immunofluorescence, clonal survival assay, flow cytometry and reactive oxygen species assay were used to explore the biological mechanism of GON sensitization. Results: GONs exhibited exceptional utility as contrast agents for both in vivo and in vitro MRI imaging. Interestingly, a single dose of 8.0 Gy X-rays together with GONs failed to confer superior therapeutic effects in tumor-bearing mice, while only 3.0 Gy × 3 fractions X-rays combined with GONs exhibited effective tumor growth inhibition. Moreover, fractionated X-ray irradiation with GONs demonstrated a superior capacity to activate the cGAS-STING pathway. Discussion: Fractionated X-ray irradiation in the presence of GONs has demonstrated the most significant activation of the anti-tumor immune response by boosting the cGAS-STING pathway.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ijn.s428044

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Graphical abstract
Graphical abstract CC BY-NC · PubMed Central
Figure 1 Characterization of GONs. The electron microscope images of GONs at 20 nm (A) and 5 nm (B) scales, where the lattice structures could be seen in the images. Partially enlarged nanocrystal image when measuring lattice spacing with the GATAN Digital Micrograph software. In Figure B, each nanocrystal particle is circled in red; the blue arrow indicates a lattice spacing between two white lines. (C) Characterizing the elemental composition of nanoparticles with EDS. (D) The distribution of oxygen elements in the field of electron microscope at the red pixel, and the distribution of gadolinium (E) in the field of electron microscope at the same green pixel. The distribution of the energy spectrum peaks of oxygen and gadolinium could also be obtained from the images.
Figure 1 Characterization of GONs. The electron microscope images of GONs at 20 nm (A) and 5 nm (B) scales, where the lattice structures could be seen in the images. Partially enlarged nanocrystal image when measuring lattice spacing with the GATAN Digital Micrograph software. In Figure B, each nanocrystal particle is circled in red; the blue arrow indicates a lattice spacing between two white lines. (C) Characterizing the elemental composition of nanoparticles with EDS. (D) The distribution of oxygen elements in the field of electron microscope at the red pixel, and the distribution of gadolinium (E) in the field of electron microscope at the same green pixel. The distribution of the energy spectrum peaks of oxygen and gadolinium could also be obtained from the images.CC BY-NC · PubMed Central
Figure 2 T1-weighted imaging (A) and T2-weighted imaging (B) of different Gd concentrations of nanoparticles with 1.0T magnetic resonance equipment. The linear fit of T1 (C) and T2 relaxation rates (D) of nanoparticles with different concentrations versus concentration and the equation of the relationship. (E) T1-weighted magnetic resonance images of different organs and tumors in mice within 2 hours after nanoparticle injection. The first row of red arrows after the tumor heading is where the mouse tumor is; the second row of red circles is where the mouse kidney is; the third row of red arrows is where the mouse liver is; we have drawn the ROI (Region of interest). (F–H) The T1 magnetic resonance signal intensity at different time points was also measured.
Figure 2 T1-weighted imaging (A) and T2-weighted imaging (B) of different Gd concentrations of nanoparticles with 1.0T magnetic resonance equipment. The linear fit of T1 (C) and T2 relaxation rates (D) of nanoparticles with different concentrations versus concentration and the equation of the relationship. (E) T1-weighted magnetic resonance images of different organs and tumors in mice within 2 hours after nanoparticle injection. The first row of red arrows after the tumor heading is where the mouse tumor is; the second row of red circles is where the mouse kidney is; the third row of red arrows is where the mouse liver is; we have drawn the ROI (Region of interest). (F–H) The T1 magnetic resonance signal intensity at different time points was also measured.CC BY-NC · PubMed Central
Figure 3 Effect of GONs pre-treatment on the cellular sensitivity to X-ray irradiation. (A) Detection of cell viability of different concentrations of gadolinium oxide nanoparticles on 4T1 cells after co-incubation proved. (B) Survival array of clones obtained by incubating GONs at different concentrations for 24 h and then X-ray irradiation. (C) By counting the number of clonal spots in different treatment groups, the survival rate of different treatment groups was calculated from this data and fitted with the linear quadratic model. (D) Detection of reactive oxygen species in different treatment groups. (E) Double-stranded DNA breaks in different treatment groups at 1 h after irradiation were detected by immunofluorescence. Red fluorescence is DNA damage foci labeled by γH2AX and blue fluorescence is nuclei labeled by DAPI. All the scale bars in the figure are 20 μm. (F) The average fluorescence intensity of double-stranded DNA damage in different treatment groups was obtained by quantifying the images obtained by laser confocal microscopy with ZEN 2.3. (G) Representative images of apoptosis in different treatment groups 24h after irradiation, and the (H) statistical graph of apoptosis ratio in different treatment groups. (I) Cell viability of cells in different treatment groups. (C, D, F and I) Data quantifications were analyzed using a Student’s t-test and expressed as mean ± s.e.m, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns means not significant.
Figure 3 Effect of GONs pre-treatment on the cellular sensitivity to X-ray irradiation. (A) Detection of cell viability of different concentrations of gadolinium oxide nanoparticles on 4T1 cells after co-incubation proved. (B) Survival array of clones obtained by incubating GONs at different concentrations for 24 h and then X-ray irradiation. (C) By counting the number of clonal spots in different treatment groups, the survival rate of different treatment groups was calculated from this data and fitted with the linear quadratic model. (D) Detection of reactive oxygen species in different treatment groups. (E) Double-stranded DNA breaks in different treatment groups at 1 h after irradiation were detected by immunofluorescence. Red fluorescence is DNA damage foci labeled by γH2AX and blue fluorescence is nuclei labeled by DAPI. All the scale bars in the figure are 20 μm. (F) The average fluorescence intensity of double-stranded DNA damage in different treatment groups was obtained by quantifying the images obtained by laser confocal microscopy with ZEN 2.3. (G) Representative images of apoptosis in different treatment groups 24h after irradiation, and the (H) statistical graph of apoptosis ratio in different treatment groups. (I) Cell viability of cells in different treatment groups. (C, D, F and I) Data quantifications were analyzed using a Student’s t-test and expressed as mean ± s.e.m, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns means not significant.CC BY-NC · PubMed Central
Figure 4 Radiation sensitization effect of GONs in vivo. Tumor growth curve (A) and survival curve (B) of mice in fractionated 8.0 Gy irradiation experiment. Tumor growth curve (C) and survival curve (D) of mice in fractionated 3.0 Gy*3 irradiation experiment. Data quantifications were analyzed using a Student’s t-test (A and C) or a Log-rank (Mantel-Cox) test (95% CI) (B and D) and expressed as mean ± s.e.m, *p < 0.05, **p < 0.01, ***p < 0.001, ns means not significant. (E) Tunel staining of tumors in the different treatment groups. All the scale bars in the figure are 100 μm. The red arrows point to cells that are Tunel-positive for apoptosis.
Figure 4 Radiation sensitization effect of GONs in vivo. Tumor growth curve (A) and survival curve (B) of mice in fractionated 8.0 Gy irradiation experiment. Tumor growth curve (C) and survival curve (D) of mice in fractionated 3.0 Gy*3 irradiation experiment. Data quantifications were analyzed using a Student’s t-test (A and C) or a Log-rank (Mantel-Cox) test (95% CI) (B and D) and expressed as mean ± s.e.m, *p < 0.05, **p < 0.01, ***p < 0.001, ns means not significant. (E) Tunel staining of tumors in the different treatment groups. All the scale bars in the figure are 100 μm. The red arrows point to cells that are Tunel-positive for apoptosis.CC BY-NC · PubMed Central
Figure 5 Western Blot was used to detect the expression of proteins associated with cGAS-STING signaling pathway. RT-qPCR was used to detect the expression of downstream signaling molecules TBK1 and IRF3. (A) WB bands and relative expression of cGAS-STING related proteins in different treatment groups in single 8.0Gy irradiation test. Relative mRNA expression levels of TBK1 (B) and IRF3 (C) in different treatment groups in a single 8.0 Gy irradiation test. (D) WB bands and relative expression of cGAS-STING related proteins in different treatment groups in fractionated 3.0 Gy*3 irradiation test. Relative mRNA expression levels of TBK1 (E) and IRF3 (F) in different treatment groups in fractionated 3.0 Gy*3 irradiation test. (B, C, E and F) Data quantifications were analyzed using a Student’s t-test and expressed as mean ± s.e.m, *p < 0.05, **p < 0.01, ***p < 0.001, ns means not significant. (G) The distribution of CD8+T cells in tumor tissues of mice treated with GONs and irradiation alone. All the scale bars in the figure are 20 μm.
Figure 5 Western Blot was used to detect the expression of proteins associated with cGAS-STING signaling pathway. RT-qPCR was used to detect the expression of downstream signaling molecules TBK1 and IRF3. (A) WB bands and relative expression of cGAS-STING related proteins in different treatment groups in single 8.0Gy irradiation test. Relative mRNA expression levels of TBK1 (B) and IRF3 (C) in different treatment groups in a single 8.0 Gy irradiation test. (D) WB bands and relative expression of cGAS-STING related proteins in different treatment groups in fractionated 3.0 Gy*3 irradiation test. Relative mRNA expression levels of TBK1 (E) and IRF3 (F) in different treatment groups in fractionated 3.0 Gy*3 irradiation test. (B, C, E and F) Data quantifications were analyzed using a Student’s t-test and expressed as mean ± s.e.m, *p < 0.05, **p < 0.01, ***p < 0.001, ns means not significant. (G) The distribution of CD8+T cells in tumor tissues of mice treated with GONs and irradiation alone. All the scale bars in the figure are 20 μm.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 25

Metadata

Authors
Yu, B., Lu, X., Feng, X., Zhao, T., Li, J., Lu, Y., Ye, F., Liu, X., Zheng, X., Shen, Z., Jin, X., Chen, W., & Li, Q.
Affiliations
  • Chinese Academy of Sciences (CN)
  • Southern Medical University (CN)
Corresponding author
Jin, Xiaodong
Venue
International Journal of Nanomedicine
Published
2023-12
Volume
Volume 18
Pages
7713-7728
ISSN
  • 1176-9114 (ISSN-L)
  • 1178-2013
OpenAlex
W4389791310
Cited by
23
References
55
Citations by year
2026: 14 · 2025: 4 · 2024: 5
FWCI
4.24
Type
journal article
Language
en
Open access
Locations
  • International Journal of Nanomedicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
  • Lanzhou University
  • National Natural Science Foundation of China (82272746, 2019/20)
  • Chinese Academy of Sciences (KFZD-SW-222)
  • Natural Science Foundation of Gansu Province (23JRRA569, 21JR7RA106)
  • West Light Foundation of the Chinese Academy of Sciences
Topics
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
Keywords
radiosensitizers, fractionated radiotherapy, cGAS-STING pathway, antitumor immunity, MRI contrast agents, 4T1 cells, radioresistance (biology), X-ray irradiation, tumor growth inhibition
MeSH terms
Animals, Gadolinium, Humans, Nucleotidyltransferases, Dose Fractionation, Radiation, Cell Line, Tumor, Mice, Nanoparticles, Triple Negative Breast Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.